EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Washington University in St. Louis
San Luis, Estados UnidosPublications in collaboration with researchers from Washington University in St. Louis (3)
2024
-
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer
JNCI Cancer Spectrum, Vol. 8, Núm. 1
2018
-
Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii91-viii92
-
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
The Lancet Oncology, Vol. 19, Núm. 6, pp. 812-824